114 related articles for article (PubMed ID: 26942090)
21. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
[TBL] [Abstract][Full Text] [Related]
22. Specific autologous anti-melanoma T cell response in vitro using monocyte-derived dendritic cells.
Soruri A; Fayyazi A; Gieseler R; Schlott T; Rünger TM; Neumann C; Peters JH
Immunobiology; 1998 Mar; 198(5):527-38. PubMed ID: 9561371
[TBL] [Abstract][Full Text] [Related]
23. Numerical defect of circulating dendritic cell subsets and defective dendritic cell generation from monocytes of patients with advanced melanoma.
Failli A; Legitimo A; Orsini G; Romanini A; Consolini R
Cancer Lett; 2013 Sep; 337(2):184-92. PubMed ID: 23684927
[TBL] [Abstract][Full Text] [Related]
24. Modulation of dendritic cell phenotype and mobility by tumor cells in vitro.
Remmel E; Terracciano L; Noppen C; Zajac P; Heberer M; Spagnoli GC; Padovan E
Hum Immunol; 2001 Jan; 62(1):39-49. PubMed ID: 11165714
[TBL] [Abstract][Full Text] [Related]
25. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Verdijk P; Aarntzen EH; Lesterhuis WJ; Boullart AC; Kok E; van Rossum MM; Strijk S; Eijckeler F; Bonenkamp JJ; Jacobs JF; Blokx W; Vankrieken JH; Joosten I; Boerman OC; Oyen WJ; Adema G; Punt CJ; Figdor CG; de Vries IJ
Clin Cancer Res; 2009 Apr; 15(7):2531-40. PubMed ID: 19318472
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells.
Mahdian R; Kokhaei P; Najar HM; Derkow K; Choudhury A; Mellstedt H
Med Oncol; 2006; 23(2):273-82. PubMed ID: 16720928
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10.
Domínguez-Soto A; Sierra-Filardi E; Puig-Kröger A; Pérez-Maceda B; Gómez-Aguado F; Corcuera MT; Sánchez-Mateos P; Corbí AL
J Immunol; 2011 Feb; 186(4):2192-200. PubMed ID: 21239715
[TBL] [Abstract][Full Text] [Related]
28. MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.
Yaddanapudi K; Rendon BE; Lamont G; Kim EJ; Al Rayyan N; Richie J; Albeituni S; Waigel S; Wise A; Mitchell RA
Cancer Immunol Res; 2016 Feb; 4(2):101-12. PubMed ID: 26603621
[TBL] [Abstract][Full Text] [Related]
29. A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.
Gupta S; Termini JM; Rivas Y; Otero M; Raffa FN; Bhat V; Farooq A; Stone GW
Vaccine; 2015 Sep; 33(38):4798-806. PubMed ID: 26241951
[TBL] [Abstract][Full Text] [Related]
30. Endotoxin-induced uveitis. Kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body.
McMenamin PG; Crewe J
Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):1949-59. PubMed ID: 7657537
[TBL] [Abstract][Full Text] [Related]
31. Tumor-induced modulation of dendritic cell function.
Gottfried E; Kreutz M; Mackensen A
Cytokine Growth Factor Rev; 2008 Feb; 19(1):65-77. PubMed ID: 18061513
[TBL] [Abstract][Full Text] [Related]
32. Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture.
Eggert AO; Becker JC; Ammon M; McLellan AD; Renner G; Merkel A; Bröcker EB; Kämpgen E
Eur J Immunol; 2002 Jan; 32(1):122-7. PubMed ID: 11754352
[TBL] [Abstract][Full Text] [Related]
33. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells.
Akiyama Y; Tanosaki R; Inoue N; Shimada M; Hotate Y; Yamamoto A; Yamazaki N; Kawashima I; Nukaya I; Takesako K; Maruyama K; Takaue Y; Yamaguchi K
J Transl Med; 2005 Jan; 3(1):4. PubMed ID: 15676080
[TBL] [Abstract][Full Text] [Related]
34. Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma.
Hotblack A; Holler A; Piapi A; Ward S; Stauss HJ; Bennett CL
Mol Ther; 2018 Jun; 26(6):1471-1481. PubMed ID: 29628306
[TBL] [Abstract][Full Text] [Related]
35. Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.
Figueiredo CR; Azevedo RA; Mousdell S; Resende-Lara PT; Ireland L; Santos A; Girola N; Cunha RLOR; Schmid MC; Polonelli L; Travassos LR; Mielgo A
Front Immunol; 2018; 9():1132. PubMed ID: 29875777
[TBL] [Abstract][Full Text] [Related]
36. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
Pietra G; Mortarini R; Parmiani G; Anichini A
Cancer Res; 2001 Nov; 61(22):8218-26. PubMed ID: 11719453
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of dendritic cells transduced with different anti-apoptotic molecules: sensitivity to tumor-induced apoptosis.
Balkir L; Tourkova IL; Makarenkova VP; Shurin GV; Robbins PD; Yin XM; Chatta G; Shurin MR
J Gene Med; 2004 May; 6(5):537-44. PubMed ID: 15133764
[TBL] [Abstract][Full Text] [Related]
38. Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors.
Bulgarelli J; Tazzari M; Granato AM; Ridolfi L; Maiocchi S; de Rosa F; Petrini M; Pancisi E; Gentili G; Vergani B; Piccinini F; Carbonaro A; Leone BE; Foschi G; Ancarani V; Framarini M; Guidoboni M
Front Immunol; 2019; 10():2353. PubMed ID: 31649669
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cells and macrophages in the uveal tract of the normal mouse eye.
McMenamin PG
Br J Ophthalmol; 1999 May; 83(5):598-604. PubMed ID: 10216062
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
